View Press Releases
-
Microway Provides Vyasa Analytics NVIDIA® DGX-1™ and NumberSmasher® GPU Server
PLYMOUTH, MA - Aug 21, 2019 - Microway, a leading provider of computational clusters, servers, and workstations for AI and HPC applications, announces it has provided an NVIDIA® DGX-1 supercomputer and Microway NumberSmasher® Tesla® GPU Server to deep-learning leader Vyasa Analytics
Aug 21, 2019
-
Signant Health Appoints Todd Everhart as Clinical Vice President to Accelerate Intelligent eCOA and Predictive Data Analytics in Medical Clinical Research
PHILADELPHIA, PA, UNITED STATES - Aug 20, 2019 - Signant Health, formerly CRF Health and Bracket, has appointed Anthony Todd Everhart, MD, FACP to the Signant Health Science and Medicine Team as Clinical Vice President, Internal Medicine, reporting to the Chief Medical Officer, Dr
Aug 20, 2019
-
Creative Diagnostics Introduces New Lyophilized Exosomes for Research
SHIRLEY, NY, UNITED STATES - Aug 20, 2019 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics announces that it has developed lyophilized exosomes for global researchers, which are isolated from different biological sources including human biofluids of certified healthy donors (plasma, serum, urine, saliva) and different cell culture supernatant
Aug 20, 2019
-
Knopp Biosciences Announces Start of Phase 2 Clinical Trial Evaluating Oral Dexpramipexole in Moderate-to-Severe Eosinophilic Asthma
PITTSBURGH, PA - Aug 19, 2019 - Knopp Biosciences LLC today announced the start of Phase 2 dose-ranging clinical trial in moderate-to-severe eosinophilic asthma
Aug 19, 2019
-
Strata Oncology Announces Partnerships with Five Additional Health Systems
BELFORD, NJ, US - Aug 16, 2019 - ANN ARBOR, Mich. -- Strata Oncology, a precision oncology company enabling molecular indications for cancer therapeutics, today announced Baptist Health (KY), Lehigh Valley Health Network (PA), Marshfield Clinic (WI), MultiCare Health System (WA), and Prisma Health (SC) have joined the Strata Precision Oncology Network (the "Network")
Aug 17, 2019
-
Creative Enzymes Has Upgraded Four Enzymes Services for Bio-researchers
NEW YORK, NY - Aug 16, 2019 - As an excellent supplier and manufacturer, Creative Enzymes recently has upgraded four enzymes related services, such as enzyme expression and purification, and enzyme engineering services for researchers working in the life science field
Aug 16, 2019
-
New BioIVT Research Examines Potential Link Between HIV Integrase Inhibitor Drugs and Neural Tube Defects During Pregnancy
WESTBURY, NY - Aug 15, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that researchers in its Transporter Sciences Group have co-authored a peer-reviewed DMD paper, which investigates the inhibitory effects of a class of HIV drugs known as integrase inhibitors on folate transporter pathways
Aug 15, 2019
-
Size really does matter when purchasing equipment for laboratories
GUILDFORD, UNITED KINGDOM - Aug 14, 2019 - Laboratories are nearly always short of space which means bulky or very heavy equipment cant be accommodated or has to be housed away from the laboratory
Aug 14, 2019
-
Creative Biolabs Has Updated Its Product Type for Therapeutic Antibodies
SHIRLEY, NY - Aug 13, 2019 - August 13, 2019, as a leading supplier and manufacturer in antibody field, Creative Biolabs recently has updated its new product types for therapeutic antibody, which has at least three types of mechanisms
Aug 13, 2019
-
AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio
RESEARCH TRIANGLE PARK, NC - Aug 13, 2019 - AskBio, the worlds foremost clinical stage and gene therapy platform company, has acquired Synpromics, the leader in gene control synthetic promoter technology, bioinformatics and intelligent data-driven design that enables more precise cell targeting and gene expression
Aug 13, 2019
-
Signant Health Launches Partner Program to Team with Clinical Research Organizations (CROs) Committed to Improving Clinical Trials with Patient-Centric Technology
PHILADELPHIA, PA, UNITED STATES - Aug 12, 2019 - Signant Health (signanthealth.com), a leading provider of technology for clinical research, today launches the Signant Health Partner Program, a significant investment the company is making to enable clinical research organizations (CROs) to better serve sponsors in the areas of Patient Data, Patient Experience, Clinical Supplies, and Endpoint Quality Solutions
Aug 12, 2019
-
Creative Enzymes Has Launched several enzymes services for Bio-researchers
NEW YORK, NY - Aug 12, 2019 - Creative Enzymes Has Launched several enzymes services for Bio-researchers SHIRLEY, NY - Aug, 2019 - As an excellent supplier and manufacturer, Creative Enzymes recently has launched five enzymes related services, such as biocatalysis service, enzyme engineering, enzyme modification, enzyme conjugation, and enzyme formulation for researchers working in the life science field
Aug 12, 2019
-
Booming Breakthrough: Creative Biolabs Enables World’s First 100% Identification of Leucine and Isoleucine in De Novo Antibody Sequencing
SHIRLEY, NY - Aug 12, 2019 - It has long been a worldwide problem to precisely identify leucine and isoleucine, not to mention 100% accuracy
Aug 12, 2019
-
Spring Bank Announces FDA Acceptance of IND Application for SB 11285, an IV-Administered STING Agonist, for the Treatment of Advanced Solid Tumors
HOPKINTON, MA, UNITED STATES - Aug 8, 2019 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, announced that its Investigational New Drug (IND) application for a Phase 1 trial of SB 11285, the companys intravenously (IV)-administered STING (STimulator of INterferon Gene) agonist development candidate, is now effective following clearance by the FDA
Aug 8, 2019
-
WCG Acquires PharmaSeek, LLC
PRINCETON, NJ - Aug 8, 2019 - The WIRB-Copernicus Group®s (WCG) Clinical Services Division announced the acquisition of PharmaSeek, LLC, including its wholly-owned subsidiaries PFS Clinical and PatientWise, leading providers of turn-key administrative, consulting, patient recruitment and training solutions for clinical research sites
Aug 8, 2019
-
Shimmer Wins Two GHP International Life Sciences Awards for its Wearable Sensor Technology
CAMBRIDGE, MA, US - Aug 7, 2019 - Shimmer Research, a global leader in wearable technology for research applications, today announced that it has been honored with two GHP International Life Sciences Awards – Best Clinical Trials Wearable Sensor Technology Company USA, and Best Researcher Wearable Wireless Technology Provider 2019
Aug 7, 2019
-
BioIVT to Host Symposium Highlighting Industry Progress in Immuno-oncology Drug Discovery Research
WESTBURY, NY - Aug 7, 2019 - Aug. 7, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it will be hosting a research symposium entitled "Innovation in Immuno-oncology: Breaking Down the Barriers" on Aug
Aug 7, 2019
-
LabTwin Partners with CA-based Biotech Shared Laboratory Community and Incubator; Bonneville Labs and Lab Launch Give Biotech Startups Access to World’s First Voice and AI-Powered Digital Lab Assistan
BERLIN, GERMANY - Jul 30, 2019 - LabTwin GmbH, the worlds first voice and AI-powered digital lab assistant, today announced partnerships with CA-based life science shared lab facilities Bonneville Labs and Lab Launch
Aug 6, 2019
-
Certara Launches BaseCase Data Manager to Enhance Value-based Customer Presentations
PRINCETON, NJ - Aug 6, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the launch of BaseCase Data Manager, which allows clients to build interactive, data-driven mobile tools using real-world data sources, such as healthcare claims, costs, quality, outcomes, and population data
Aug 6, 2019
-
BioIVT Acquires Keystone Biologicals, Expands its Offering of Disease-state Biospecimens
WESTBURY, NY - Aug 6, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has acquired Keystone Biologicals, Inc
Aug 6, 2019